Incorporating a Prognostic Gene Expression Profile Test into the Management of Cutaneous Squamous Cell Carcinoma: An Expert Consensus Panel Report

February 2024 | Volume 23 | Issue 2 | 54 | Copyright © February 2024


Published online November 16, 2023

Danny Zakria MD MBAa, Nicholas Brownstone MDb, Brian Berman MDc, Roger Ceilley MDd, Terrence A. Cronin Jr. MDc, James Q. Del Rosso DOe, Laura K. Ferris MD PhDf, Gary Goldenberg MDa, Daniel Siegel MDg

aDepartment of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY
bDepartment of Dermatology, Temple University Health, Philadelphia, PA
cDepartment of Dermatology & Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL
dDepartment of Dermatology, The University of Iowa, Iowa City, IA
eDepartment of Dermatology, Touro University, Henderson, NV
fDepartment of Dermatology, University of Pittsburgh Medical Center, Pittsburgh, PA
gDepartment of Dermatology, SUNY Downstate, Brooklyn, NY

  1. Hsu C-C, Sandford BA. The Delphi technique: making sense of consensus. Practical Assessment, Research, and Evaluation. 2007;12:1-8.
  2. Berman B, Ceilley R, Cockerell C, et al. Appropriate use criteria for the integration of diagnostic and prognostic gene expression profile assays into the management of cutaneous malignant melanoma: an expert panel consensus-based modified delphi process assessment. SKIN The Journal of Cutaneous Medicine. 2019;3(5):291–306. doi:10.25251/skin.3.5.1
  3. Thiboutot DM, Dréno B, Abanmi A, et al. Practical management of acne for clinicians: An international consensus from the Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2018;78(2 Suppl 1):S1-S23.e1. doi:10.1016/j.jaad.2017.09.078 
  4. Richard MA, Barnetche T, Rouzaud M, et al. Evidence-based recommendations on the role of dermatologists in the diagnosis and management of psoriatic arthritis: systematic review and expert opinion. J Eur Acad Dermatol Venereol. 2014;28 Suppl 5:3-12. doi:10.1111/jdv.12560
  5. Zakria D, Brownstone N, Berman B, et al. Incorporating prognostic gene expression profile assays into the management of cutaneous melanoma: an expert consensus panel report. SKIN The Journal of Cutaneous Medicine. 2023;7(1):556–569. https://doi.org/10.25251/skin.7.1.1
  6. Cañueto J, Cardeñoso-Álvarez E, Cosano-Quero A, et al. The expression of podoplanin is associated with poor outcomes in cutaneous squamous cell carcinoma. J Cutan Pathol. 2017;44(2):144-151. doi:10.1111/cup.12859
  7. Chen MK, Cai MY, Luo RZ, et al. Overexpression of p300 correlates with poor prognosis in patients with cutaneous squamous cell carcinoma. Br J Dermatol. 2015;172(1):111-119. doi:10.1111/bjd.13226
  8. Li YY, Hanna GJ, Laga AC, Haddad RI, Lorch JH, Hammerman PS. Genomic analysis of metastatic cutaneous squamous cell carcinoma. Clin Cancer Res. 2015;21(6):1447-1456. doi:10.1158/1078-0432.CCR-14-1773
  9. Vinicius de LV, Scapulatempo C, Perpetuo NM, et al. Prognostic and risk factors in patients with locally advanced cutaneous squamous cell carcinoma of the trunk and extremities. J Skin Cancer. 2011;2011:420796. doi:10.1155/2011/420796
  10. Xu R, Cai MY, Luo RZ, et al. The Expression Status and Prognostic Value of Cancer Stem Cell Biomarker CD133 in Cutaneous Squamous Cell Carcinoma. JAMA Dermatol. 2016;152(3):305-311. doi:10.1001/jamadermatol.2015.3781
  11. Al-Rohil RN, Tarasen AJ, Carlson JA, et al. Evaluation of 122 advancedstage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies. Cancer. 2016;122(2):249-257. doi:10.1002/cncr.29738 
  12. Campos MA, Macedo S, Fernandes MS, et al. Prognostic Significance of RAS Mutations and P53 Expression in Cutaneous Squamous Cell Carcinomas. Genes (Basel). 2020;11(7):751. Published 2020 Jul 6. doi:10.3390/ genes11070751
  13. Kitrell BM, Blue ED, Siller A Jr, et al. Gene Expression Profiles in Cutaneous Oncology. Dermatol Clin. 2023;41(1):89-99. doi:10.1016/j.det.2022.07.018
  14. Newman JG, Hall MA, Kurley SJ, et al. Adjuvant therapy for highrisk cutaneous squamous cell carcinoma: 10-year review. Head Neck. 2021;43(9):2822-2843. doi:10.1002/hed.26767
  15. Zilberg C, Lee MW, Yu B, et al. Analysis of clinically relevant somatic mutations in high-risk head and neck cutaneous squamous cell carcinoma. Mod Pathol. 2018;31(2):275-287. doi:10.1038/modpathol.2017.128

AUTHOR CORRESPONDENCE

Danny Zakria MD MBA dzakria13@gmail.com
Close Menu